Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.3M Sell
337,264
-1,202,785
-78% -$56.1M 0.33% 70
2026
Q1
$55.6M Buy
1,540,049
+222,927
+17% +$9.33M 0.95% 33
2025
Q4
$62M Buy
1,317,122
+601,904
+84% +$25.4M 0.99% 30
2025
Q3
$23.2M Buy
+715,218
New +$25.5M 0.32% 67

Other funds holding BRKR

Samlyn Capital's BRKR Position: Q2 2026 in Review

Samlyn Capital reduced its Bruker (BRKR) stake by 78% in Q2 2026, selling an estimated $56.1M and leaving 337,264 shares worth $20.3M. The position accounts for 0.33% of the portfolio, ranked #70.

Samlyn Capital first reported a position in BRKR in Q3 2025 and has held it in 4 quarters since. The position peaked at $62M in Q4 2025. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Samlyn Capital held 337,264 shares of Bruker worth $20.3M as of Q2 2026.
  • Samlyn Capital sold 1,202,785 Bruker shares in Q2 2026, an estimated $56.1M.
  • Bruker made up 0.33% of Samlyn Capital's portfolio in Q2 2026, its #70 holding.
  • Samlyn Capital first reported a position in Bruker in Q3 2025 and has held it in 4 quarters since.
  • Samlyn Capital's Bruker position peaked at $62M in Q4 2025.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Samlyn Capital's 13F filing for Q2 2026, filed 14 Aug 2026.